VERTEX PHARMACEUTICALS INC / MA Financing Cash Flow 2008-2026 | VRTX
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is VERTEX PHARMACEUTICALS INC / MA's current financing cash flow?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual financing cash flow for 2025 was $-2.26B, a 51.27% decline from 2024. VERTEX PHARMACEUTICALS INC / MA financing cash flow for the quarter ending March 31, 2026 was $-538.8M.
What was VERTEX PHARMACEUTICALS INC / MA's financing cash flow in 2024?
VERTEX PHARMACEUTICALS INC / MA annual financing cash flow for 2024 was $-1.49B, a 165.90% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's financing cash flow in 2023?
VERTEX PHARMACEUTICALS INC / MA annual financing cash flow for 2023 was $-562.2M, a 730.43% decline from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGRN/A
FY2020
$-505.3M
→
FY2025
$-2.26B
080910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-2.26B | -51.3% | 10-K |
| FY2024 | $-1.49B | -165.9% | 10-K |
| FY2023 | $-562.2M | -730.4% | 10-K |
| FY2022 | $-67.7M | +95.4% | 10-K |
| FY2021 | $-1.48B | -192.5% | 10-K |
| FY2020 | $-505.3M | -498.5% | 10-K |
| FY2019 | $126.8M | +278.0% | 10-K |
| FY2018 | $-71.2M | -204.1% | 10-K |
| FY2017 | $68.4M | -48.7% | 10-K |
| FY2016 | $133.3M | -29.5% | 10-K |
| FY2015 | $188.9M | -65.6% | 10-K |
| FY2014 | $549.2M | +121.1% | 10-K |
| FY2013 | $248.4M | +44.3% | 10-K |
| FY2012 | $172.2M | +238.6% | 10-K |
| FY2011 | $-124.2M | -129.2% | 10-K |
| FY2010 | $425.1M | -57.5% | 10-K |
| FY2009 | $999.0M | +60.9% | 10-K |
| FY2008 | $620.7M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →